CD101 IV

DRUG2 trials

Sponsors

Cidara Therapeutics Inc.

Conditions

Healthy

Phase 1

A Single Ascending Dose Study of CD101 IV in Healthy Subjects

CompletedNCT02516904

Cidara Therapeutics Inc.Healthy

Start: 2015-07-31End: 2015-10-31Updated: 2024-05-22

An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects

CompletedNCT02551549

Cidara Therapeutics Inc.Healthy

Start: 2015-09-30End: 2016-01-31Updated: 2017-06-26